The global diabetes market is experiencing exponential expansion driven by the increasing prevalence of this chronic disease. At the forefront of this evolution are leading companies of GLP-1 receptor agonists, a class https://socialistener.com/story5868136/leading-glp-1-manufacturers-innovation-in-diabetes-treatment